Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
China channel feed
Biosecure lawmakers tell trade groups that China studies are a new focus
11 months ago
Deals
China corruption crackdown hits Merck’s Gardasil sales, spooking investors
11 months ago
Pharma
WuXi AppTec sees US revenue decline amid Biosecure threat
11 months ago
Manufacturing
BeiGene plots to further build its manufacturing muscle outside of China
11 months ago
Manufacturing
Chinese biotech developing semaglutide biosimilar files for Hong Kong IPO
11 months ago
Financing
WuXi AppTec more than tripled lobbying spend as Biosecure Act advanced in Congress
11 months ago
Law
China approves Eli Lilly's weight loss drug as country launches obesity awareness campaign
11 months ago
Pharma
OrbiMed forms biotech with assets from China-based Keymed, enlists former Biohaven exec as CEO
11 months ago
Financing
Startups
Chinese drugmakers still lag in R&D depth despite outpacing Europeans in new launches
Last year
R&D
Pharma
House speaker plans vote on Biosecure Act as part of China legislation push
Last year
Pharma
As confidence falls, biopharma companies take precautions with Chinese partnerships, survey finds
Last year
Outsourcing
Manufacturing
Commercial-stage blood cancer biotech files for US dual listing
Last year
Financing
Day One enters ADC field, going after a target that once attracted AbbVie and now Genmab
Last year
Deals
AI drug discovery startup goes public in Hong Kong, nabbing $115M to build on pharma partnerships
Last year
Financing
AI
China biotech ban does not make the cut as add-on to defense spending bill
Last year
Law
BIO's new CEO takes a patriotic pivot to win back Congress, pushing industry to rethink China relationship
Last year
In Focus
FDA hands Chinese drug manufacturer a Form 483 noting employees destroyed documents
Last year
FDA+
Manufacturing
Novo Holdings’ head of Asia on investing in ‘China for China,’ and staying out of biotech (for now)
Last year
Financing
Pharma
Updated: With a promising new Keytruda contender, Summit prepares to spar with Merck
Last year
R&D
Pharma
GenFleet highlights Phase 2 data on KRAS/EGFR combo in lung cancer
Last year
R&D
BioNTech doubles down on ADC partner MediLink in new $1.8B biobucks pact
Last year
Startups
Deals
Nuvation Bio shares pivotal China data for cancer drug from AnHeart buyout
Last year
R&D
Merck KGaA avoids prosecution after cooperating with DOJ to uncover China export scheme
Last year
Law
Takeda enters hot molecular glue space in up to $1.2B pact with Degron
Last year
Startups
Pharma
First page
Previous page
3
4
5
6
7
8
9
Next page
Last page